Insider · CIK 0001791413

Hanley Jr. Michael Conick

Reports to the SEC for 2 companies · MOUTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001791413

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-11	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)A Award	CHIEF OPERATING OFFICER	AAward	+131K sh	—	—	131,000
2025-07-03	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)A Award	CHIEF OPERATING OFFICER	AAward	+8,000 sh	—	—	8,000
2025-07-03	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	CHIEF OPERATING OFFICER	DDisposition to Issuer	−8,000 sh	—	—	0
2025-07-03	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)A Award	CHIEF OPERATING OFFICER	AAward	+188K sh	—	—	188,000
2025-07-03	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	CHIEF OPERATING OFFICER	DDisposition to Issuer	−188K sh	—	—	0
2025-07-03	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)A Award	CHIEF OPERATING OFFICER	AAward	+125K sh	—	—	125,000
2025-07-03	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	CHIEF OPERATING OFFICER	DDisposition to Issuer	−125K sh	—	—	0
2025-02-05	ANROAlto Neuroscience, Inc. · Employee Stock Option (Right to Buy)A Award	CHIEF OPERATING OFFICER	AAward	+125K sh	—	—	125,000
2024-05-20	ANROAlto Neuroscience, Inc. · Employee Stock Option (right to buy)A Award	CHIEF OPERATING OFFICER	AAward	+188K sh	—	—	188,000
2023-02-23	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+500K sh	—	—	500,000
2022-08-23	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+130K sh	—	—	130,000
2022-06-08	SYRESpyre Therapeutics, Inc.P Purchase	Chief Business Officer	PPurchase	+28.2K sh	$0.71	+$20K	36,200
2022-02-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+160K sh	—	—	160,000
2021-02-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+135K sh	—	—	135,000
2020-02-14	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+25K sh	—	—	25,000
2019-10-21	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+130K sh	—	—	130,000

Recent filings

Accepted (ET)
Feb 134
Hanley Jr. Michael Conick0001791413-26-000001
SEC(opens sec.gov)
Jul 84
Hanley Jr. Michael Conick0001999480-25-000065
SEC(opens sec.gov)
Feb 74
Hanley Jr. Michael Conick0001999480-25-000016
SEC(opens sec.gov)
May 224
Hanley Jr. Michael Conick0001415889-24-014118
SEC(opens sec.gov)
Feb 244
Hanley Jr. Michael Conick0001209191-23-012877
SEC(opens sec.gov)
Aug 254
Hanley Jr. Michael Conick0001209191-22-047649
SEC(opens sec.gov)
Jun 104
Hanley Jr. Michael Conick0001209191-22-036085
SEC(opens sec.gov)
Feb 224
Hanley Jr. Michael Conick0001209191-22-011708
SEC(opens sec.gov)
Feb 194
Hanley Jr. Michael Conick0001209191-21-012423
SEC(opens sec.gov)
Feb 194
Hanley Jr. Michael Conick0001567619-20-004315
SEC(opens sec.gov)
Oct 234
Hanley Jr. Michael Conick0001567619-19-019922
SEC(opens sec.gov)

Companies

Address

C/O ALTO NEUROSCIENCE, INC. 650 CASTRO STREET, SUITE 450

MOUTAIN VIEW, CA, 94041